PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Company ReportsMallinckrodt
Mallinckrodt(MNK)
Mallinckrodt Pharmaceuticals is an American-Irish domiciled manufacturer of specialty pharmaceuticals (namely, adrenocorticotropic hormone), generic drugs and imaging agents. In 2017 it generated 90% of its sales from the U.S. healthcare system. While Mallinckrodt is headquartered in Ireland for tax purposes, its operational headquarters are in the U.S. Mallinckrodt's 2013 tax inversion to Ireland drew controversy when it was shown Acthar was Medicaid's most expensive drug.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
ActharCorticotropin1982-01-012041
AnexsiaAcetaminophen, Hydrocodone2002-10-312025-2039
Angio-conrayIothalamate1982-01-01
—
BarosBicarbonate, Tartaric acid1985-08-07
—
BucetAcetaminophen, Butalbital1985-06-282025-2039
Butalbital, acetaminophen caffeineAcetaminophen, Butalbital, Caffeine1985-03-272025-2039
CholebrineIocetamic acid1982-01-01
—
ConrayIothalamate1982-01-01
—
FemcetAcetaminophen, Butalbital, Caffeine1985-06-192025-2039
Hydrocodone acetaminophenAcetaminophen, Hydrocodone1995-06-012025-2039
1
2
3
4
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Oxycodone
Acetaminophen
Benzocaine
Antithrombin iii
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use